Condensed Statement of Shareholders' Equity (Unaudited) - USD ($) |
Total |
Previously Reported [Member] |
Cumulative Effect, Period of Adoption, Adjustment [Member] |
Cumulative Effect, Period of Adoption, Adjusted Balance [Member] |
Convertible Preferred Stock [Member]
Previously Reported [Member]
|
Convertible Preferred Stock [Member]
Cumulative Effect, Period of Adoption, Adjustment [Member]
|
Series P-2 Convertible Preferred Stock [Member] |
Common Stock [Member] |
Common Stock [Member]
Previously Reported [Member]
|
Common Stock [Member]
Cumulative Effect, Period of Adoption, Adjustment [Member]
|
Common Stock [Member]
Cumulative Effect, Period of Adoption, Adjusted Balance [Member]
|
Common Stock [Member]
Series P-2 Convertible Preferred Stock [Member]
|
Additional Paid in Capital [Member] |
Additional Paid in Capital [Member]
Previously Reported [Member]
|
Additional Paid in Capital [Member]
Cumulative Effect, Period of Adoption, Adjustment [Member]
|
Additional Paid in Capital [Member]
Cumulative Effect, Period of Adoption, Adjusted Balance [Member]
|
Additional Paid in Capital [Member]
Series P-2 Convertible Preferred Stock [Member]
|
Accumulated Deficit [Member] |
Accumulated Deficit [Member]
Previously Reported [Member]
|
Accumulated Deficit [Member]
Cumulative Effect, Period of Adoption, Adjustment [Member]
|
Accumulated Deficit [Member]
Cumulative Effect, Period of Adoption, Adjusted Balance [Member]
|
Accumulated Deficit [Member]
Series P-2 Convertible Preferred Stock [Member]
|
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Beginning balance at Dec. 31, 2019 | $ (126,943,000) | $ 129,921,000 | $ 2,978,000 | $ 129,921,000 | $ (129,921,000) | $ 59,000 | $ (53,000) | $ 6,000 | $ 40,626,000 | $ 129,974,000 | $ 170,600,000 | $ (167,628,000) | $ 0 | $ (167,628,000) | ||||||||
Beginning balance, Shares at Dec. 31, 2019 | 153,758,348 | (153,758,348) | 65,196,490 | (1,992,064) | 63,204,426 | |||||||||||||||||
Issuance of common stock upon exercise of stock options Shares | 5,260 | |||||||||||||||||||||
Vesting of early exercised stock options | $ 6,000 | $ 6,000 | $ 0 | |||||||||||||||||||
Issuance of series P-2 Preferred stock | $ 29,012,000 | $ 1,000 | $ 29,011,000 | $ 0 | ||||||||||||||||||
Issuance of series P-2 Preferred stock Number of shares issued | 12,488,024 | |||||||||||||||||||||
Conversion of promissory notes to Series P-2 convertible preferred stock | 3,507,984 | |||||||||||||||||||||
Conversion of promissory notes to Series P-2 convertible preferred stock Shares | 8,203,000 | 8,203,000 | ||||||||||||||||||||
Stock-based compensation | 58,000 | 58,000 | 0 | |||||||||||||||||||
Net loss | (7,682,000) | (7,682,000) | ||||||||||||||||||||
Ending balance at Mar. 31, 2020 | 32,575,000 | $ 7,000 | 207,878,000 | (175,310,000) | ||||||||||||||||||
Ending balance, Shares at Mar. 31, 2020 | 79,205,694 | |||||||||||||||||||||
Beginning balance at Dec. 31, 2019 | (126,943,000) | 129,921,000 | 2,978,000 | $ 129,921,000 | $ (129,921,000) | $ 59,000 | $ (53,000) | $ 6,000 | 40,626,000 | 129,974,000 | 170,600,000 | (167,628,000) | $ 0 | (167,628,000) | ||||||||
Beginning balance, Shares at Dec. 31, 2019 | 153,758,348 | (153,758,348) | 65,196,490 | (1,992,064) | 63,204,426 | |||||||||||||||||
Net loss | (26,308,000) | |||||||||||||||||||||
Ending balance at Sep. 30, 2020 | 43,361,000 | $ 9,000 | 237,288,000 | (193,936,000) | ||||||||||||||||||
Ending balance, Shares at Sep. 30, 2020 | 92,160,168 | |||||||||||||||||||||
Beginning balance at Mar. 31, 2020 | 32,575,000 | $ 7,000 | 207,878,000 | (175,310,000) | ||||||||||||||||||
Beginning balance, Shares at Mar. 31, 2020 | 79,205,694 | |||||||||||||||||||||
Vesting of early exercised stock options | 6,000 | 6,000 | 0 | |||||||||||||||||||
Issuance of series P-2 Preferred stock | 10,201,000 | 10,200,000 | 0 | |||||||||||||||||||
Issuance of series P-2 Preferred stock Number of shares issued | 4,538,706 | |||||||||||||||||||||
Stock-based compensation | 58,000 | 58,000 | 0 | |||||||||||||||||||
Net loss | (5,150,000) | (5,150,000) | ||||||||||||||||||||
Ending balance at Jun. 30, 2020 | 37,690,000 | $ 8,000 | 218,142,000 | (180,460,000) | ||||||||||||||||||
Ending balance, Shares at Jun. 30, 2020 | 83,744,400 | |||||||||||||||||||||
Issuance of common stock upon exercise of stock options Shares | 118,448 | |||||||||||||||||||||
Vesting of early exercised stock options | 4,000 | 4,000 | 0 | |||||||||||||||||||
Issuance of series P-2 Preferred stock | $ 19,062,000 | $ 1,000 | $ 19,061,000 | $ 0 | ||||||||||||||||||
Issuance of series P-2 Preferred stock Number of shares issued | 8,300,550 | |||||||||||||||||||||
Repurchase of unvested restricted common stock, Shares | (3,230) | |||||||||||||||||||||
Stock-based compensation | 81,000 | 81,000 | 0 | |||||||||||||||||||
Net loss | (13,476,000) | (13,476,000) | ||||||||||||||||||||
Ending balance at Sep. 30, 2020 | 43,361,000 | $ 9,000 | 237,288,000 | (193,936,000) | ||||||||||||||||||
Ending balance, Shares at Sep. 30, 2020 | 92,160,168 | |||||||||||||||||||||
Beginning balance at Dec. 31, 2020 | $ 36,216,000 | (165,840,000) | 202,056,000 | 36,216,000 | $ 202,056,000 | $ (202,056,000) | $ 65,000 | $ (55,000) | $ 10,000 | 41,373,000 | 202,111,000 | 243,484,000 | (207,278,000) | (207,278,000) | ||||||||
Beginning balance, Shares at Dec. 31, 2020 | 100,016,559 | 324,370,424 | 324,370,424 | 93,986,381 | 6,030,178 | 100,016,559 | ||||||||||||||||
Issuance of common stock upon exercise of stock options Value | $ 30,000 | 30,000 | ||||||||||||||||||||
Issuance of common stock upon exercise of stock options Shares | 2,112,373 | |||||||||||||||||||||
Vesting of early exercised stock options | 24,000 | 24,000 | ||||||||||||||||||||
Repurchase of unvested restricted common stock, Shares | (87,768) | |||||||||||||||||||||
Issuance of Series D convertible preferred stock upon exercise of warrants | 20,877,000 | 20,877,000 | ||||||||||||||||||||
Issuance of Series D convertible preferred stock upon exercise of warrants Shares | 2,020,034 | |||||||||||||||||||||
Stock-based compensation | 1,555,000 | 1,555,000 | ||||||||||||||||||||
Net loss | (16,165,000) | (16,165,000) | ||||||||||||||||||||
Ending balance at Mar. 31, 2021 | 42,537,000 | $ 10,000 | 265,970,000 | (223,443,000) | ||||||||||||||||||
Ending balance, Shares at Mar. 31, 2021 | 104,061,198 | |||||||||||||||||||||
Beginning balance at Dec. 31, 2020 | $ 36,216,000 | $ (165,840,000) | $ 202,056,000 | $ 36,216,000 | $ 202,056,000 | $ (202,056,000) | $ 65,000 | $ (55,000) | $ 10,000 | $ 41,373,000 | $ 202,111,000 | $ 243,484,000 | $ (207,278,000) | $ (207,278,000) | ||||||||
Beginning balance, Shares at Dec. 31, 2020 | 100,016,559 | 324,370,424 | 324,370,424 | 93,986,381 | 6,030,178 | 100,016,559 | ||||||||||||||||
Issuance of common stock upon exercise of stock options Shares | 2,121,815 | |||||||||||||||||||||
Net loss | $ (41,306,000) | |||||||||||||||||||||
Ending balance at Oct. 03, 2021 | $ 323,706,000 | $ 14,000 | 572,276,000 | (248,584,000) | ||||||||||||||||||
Ending balance, Shares at Oct. 03, 2021 | 145,185,904 | 145,185,904 | ||||||||||||||||||||
Beginning balance at Mar. 31, 2021 | $ 42,537,000 | $ 10,000 | 265,970,000 | (223,443,000) | ||||||||||||||||||
Beginning balance, Shares at Mar. 31, 2021 | 104,061,198 | |||||||||||||||||||||
Issuance of common stock upon exercise of stock options Value | 4,000 | 4 | ||||||||||||||||||||
Issuance of common stock upon exercise of stock options Shares | 9,442 | |||||||||||||||||||||
Vesting of early exercised stock options | 29,000 | 29,000 | ||||||||||||||||||||
Repurchase of unvested restricted common stock, Shares | (75,111) | |||||||||||||||||||||
Stock-based compensation | 2,353,000 | 2,353,000 | ||||||||||||||||||||
Net loss | (14,303,000) | (14,303,000) | ||||||||||||||||||||
Ending balance at Jun. 30, 2021 | 30,620,000 | $ 10,000 | 268,356,000 | (237,746,000) | ||||||||||||||||||
Ending balance, Shares at Jun. 30, 2021 | 103,995,529 | |||||||||||||||||||||
Business combination, net of redemptions and equity issuance costs and PIPE financing, net | 300,745,000 | $ 4,000 | 300,741,000 | |||||||||||||||||||
Business combination, net of redemptions and equity issuance costs and PIPE financing, net. shares | 41,249,985 | |||||||||||||||||||||
Vesting of early exercised stock options | 29,000 | 29,000 | ||||||||||||||||||||
Repurchase of unvested restricted common stock, Shares | (59,610) | |||||||||||||||||||||
Stock-based compensation | 3,150,000 | 3,150,000 | ||||||||||||||||||||
Net loss | (10,838,000) | (10,838,000) | ||||||||||||||||||||
Ending balance at Oct. 03, 2021 | $ 323,706,000 | $ 14,000 | $ 572,276,000 | $ (248,584,000) | ||||||||||||||||||
Ending balance, Shares at Oct. 03, 2021 | 145,185,904 | 145,185,904 |